Europe's Choice
Geopolitical shifts are reshaping life sciences. Europe can build on its strengths and lead or stand still and fall behind. What will it choose?
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA is asking EU leaders to work together with industry to create opportunities to, once again, make the region a world-leader in life sciences
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
Blog articles 12.03.26
Cancer care is becoming more efficient – Better outcomes without escalating costs (Guest blog)
Europe is achieving better cancer outcomes without cancer overwhelming health budgets. In fact, cancer care is delivering increasing value for money.
Read Article -
Blog articles 12.03.26
Public-private partnerships: How the Innovative Health Initiative (IHI) is driving progress
From AMR and AI to big data and regulatory innovation, IHI projects are tackling Europe’s priority health challenges
Read Article -
Statements & press releases 05.03.26
Better European Coordination Urgently Needed to Improve Access to Targeted Cancer Treatments
How to translate scientific progress in a more targeted and personalized treatment of cancer into equitable access for patients.
Read Article -
External Event 19.03.26
J&J | The essentials of partnering with a pharma company
Discover what it takes to build successful collaborations with pharmaceutical companies and accelerate your innovation to patients.
View Event -
External Event 24.03.26
DIA Europe 2026
Join the DIA Europe 2026 in March to explore how Europe can bring and keep innovation into the system to deliver better outcomes for patients.
View Event -
EFPIA Event 21.04.26
Europe’s Choice: Investing in sustainable health systems
At a time when health budgets are strained, public finances are under pressure, the health workforce crisis is deepening, and Europe faces unprecedented...
View Event